Okemos, MI, United States of America

Thomas Krigas


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 1979-1996

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Thomas Krigas

Introduction

Thomas Krigas is a notable inventor based in Okemos, Michigan, recognized for his significant contributions to the field of medical technology. With a total of three patents to his name, Krigas has focused on developing innovative anti-tumor methods that have the potential to improve treatment outcomes for animals suffering from malignant tumors.

Latest Patents

Krigas's latest patents include two related anti-tumor methods. The first patent describes a technique for treating malignant tumors in animals by parenterally administering a solution containing a complex compound of platinum. This method is designed to effectively cause regression of the tumor. The second patent also addresses the treatment of malignant tumor cells sensitive to platinum coordination compounds in animals, utilizing a similar approach to achieve tumor regression.

Career Highlights

Throughout his career, Thomas Krigas has worked with various organizations, including Research Incorporated and Research Corporation Technologies, Inc. His work has been instrumental in advancing the understanding and treatment of cancer in veterinary medicine.

Collaborations

Krigas has collaborated with notable individuals in his field, including Barnett Rosenberg and Loretta Vancamp. These partnerships have contributed to the development of his innovative approaches to cancer treatment.

Conclusion

Thomas Krigas's work in developing anti-tumor methods showcases his dedication to improving animal health through innovative solutions. His contributions to the field are significant and reflect his commitment to advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…